Home › Ulcerative Colitis › South Carolina › Charleston
Ulcerative Colitis clinical trials in Charleston, SC
4 studies for Ulcerative Colitis are looking for participants at sites in and around Charleston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 2
- Medical University of South Carolina, Charleston
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
RecruitingObservational study
- Medical University of South Carolina (MUSC), Charleston
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
RecruitingPhase 2/3
- Local Institution - 0099, Charleston
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
RecruitingPhase 3
- Medical University of South Carolina, Charleston
About Ulcerative Colitis
Ulcerative Colitis (UC) can cause long-lasting swelling and ulcers in the large intestine. It is a type of inflammatory bowel disease. Find out more.
More about Ulcerative Colitis on MedlinePlus
Ulcerative Colitis trials in other cities
- Orlando, FL21 studies
- New York City, NY21 studies
- Miami, FL20 studies
- Houston, TX14 studies
- San Diego, CA13 studies
- Chicago, IL13 studies
- Tacoma, WA13 studies
- St. Louis, MO13 studies
- Tyler, TX13 studies
- San Antonio, TX13 studies
- Colorado Springs, CO12 studies
- Boston, MA12 studies
Other studies in Charleston
- Stroke19 studies
- Depression18 studies
- Post-Traumatic Stress Disorder16 studies
- Head and Neck Squamous Cell Carcinoma16 studies
- Heart Failure16 studies
- Non-Small Cell Lung Cancer16 studies
- Prostate Cancer16 studies
- Cardiovascular Disease16 studies
- Cancer (all types)14 studies
- Parkinson's Disease13 studies
- Breast Cancer12 studies
- Lung Cancer12 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.